医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2013年
9期
93-94
,共2页
埃索美拉唑%莫沙必利分散片%硫糖铝混悬液%反流性食管炎
埃索美拉唑%莫沙必利分散片%硫糖鋁混懸液%反流性食管炎
애색미랍서%막사필리분산편%류당려혼현액%반류성식관염
Esomeprozole%Mosapride%dispersible fablets%refluxesophagitis
目的观察埃索美拉唑联合硫糖铝混悬液治疗反流性食管炎临床疗效观察.方法62例经胃镜检查确诊为反流性食管炎的患者随机分为治疗组和对照组,两组均口服埃索美拉唑40 mg,2次/每天,莫沙必利分散片5 mg,3次/每天;治疗组联合硫糖铝混悬液口服10 ml/次,4次/d,治疗4周.结果治疗后两组患者临床症状及胃镜结果均明显好转,治疗组优于对照组(P<0.05).结论埃索美拉唑联合硫糖铝混悬液治疗反流性食管炎有良好的协同作同,安全有效.
目的觀察埃索美拉唑聯閤硫糖鋁混懸液治療反流性食管炎臨床療效觀察.方法62例經胃鏡檢查確診為反流性食管炎的患者隨機分為治療組和對照組,兩組均口服埃索美拉唑40 mg,2次/每天,莫沙必利分散片5 mg,3次/每天;治療組聯閤硫糖鋁混懸液口服10 ml/次,4次/d,治療4週.結果治療後兩組患者臨床癥狀及胃鏡結果均明顯好轉,治療組優于對照組(P<0.05).結論埃索美拉唑聯閤硫糖鋁混懸液治療反流性食管炎有良好的協同作同,安全有效.
목적관찰애색미랍서연합류당려혼현액치료반류성식관염림상료효관찰.방법62례경위경검사학진위반류성식관염적환자수궤분위치료조화대조조,량조균구복애색미랍서40 mg,2차/매천,막사필리분산편5 mg,3차/매천;치료조연합류당려혼현액구복10 ml/차,4차/d,치료4주.결과치료후량조환자림상증상급위경결과균명현호전,치료조우우대조조(P<0.05).결론애색미랍서연합류당려혼현액치료반류성식관염유량호적협동작동,안전유효.
Objective To observe clinical curative effects on reflux esophagitis patients after Esomeprazole and Sucralfate suspension. Methods:Divided the 62 patients diagnosed as RE by gastroscopy into two groups:treatment group and control group, they al received oral Esomeprazole 40mg,twice a day,Mosapride dispersible tablets 5mg, three times; treatment group received additional oral Sucralfate suspension 10ml,four times a day,lasting for 4 weeks. Results the clinical symptoms and gastroscopy results of two groups were significantly improved,the treatment group was better than control group(P<0.05). Conclusion Esomeprazole combined with Sucralfate suspension in the treatment of reflux esophagitis worked wel,safe and effective.